Royal College of Physicians (RCP) academic vice president Professor Margaret Johnson responds to the publication today of the government’s policy paper, Collaboration on science and innovation: a future partnership paper.
Professor Johnson said:
This document communicates the UK’s intention to continue a positive, collaborative approach to science, research and technology with the EU. We consider this to be a promising indication that the UK government has listened to and acted upon the concerns of the sector.
The work of the EU is crucial for advancements in medical research, particularly ensuring patients have access to the best treatments possible. Today’s announcement is a clear acknowledgement of the UK’s important global role in research.
As we recommend in our briefing Brexit: What does it mean for medical research? the government must now provide reassurance that as negotiations for exiting the European Union continue, patients will also be able to continue to participate in high-quality research.
The MHRA [Medicines and Healthcare products Regulatory Agency] should also continue to provide advice and act as a leader of regulation globally, working collaboratively with the EMA [European Medicines Agency] so that the UK remains an attractive place to invest, ensuring that there is no delay for patients accessing new treatments.